Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
<p>Abstract</p> <p>Background</p> <p>The Acute Respiratory Distress Syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS. The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentr...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2011-05-01
|
| Серія: | Trials |
| Онлайн доступ: | http://www.trialsjournal.com/content/12/1/113 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|